These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36285600)

  • 21. Challenges and successes in the implementation of option B+ to prevent mother-to-child transmission of HIV in southern Swaziland.
    Etoori D; Kerschberger B; Staderini N; Ndlangamandla M; Nhlabatsi B; Jobanputra K; Mthethwa-Hleza S; Parker LA; Sibanda S; Mabhena E; Pasipamire M; Kabore SM; Rusch B; Jamet C; Ciglenecki I; Teck R
    BMC Public Health; 2018 Mar; 18(1):374. PubMed ID: 29558896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
    Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
    Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Structured Mentor Mother Programs on Presentation for Early Infant Diagnosis Testing in Rural North-Central Nigeria: A Prospective Paired Cohort Study.
    Sam-Agudu NA; Ramadhani HO; Isah C; Erekaha S; Fan-Osuala C; Anaba U; Adejuyigbe EA; Charurat M
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S182-S189. PubMed ID: 28498188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Male involvement enhances the uptake of early infant diagnosis of HIV services in Thyolo, Malawi: A non-equivalent control group quasi-experimental study.
    Window M; Nyondo-Mipando AL; Kalanga N
    PLoS One; 2023; 18(2):e0281105. PubMed ID: 36812286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receipt of infant HIV DNA PCR test results is associated with a reduction in retention of HIV-exposed infants in integrated HIV care and healthcare services: a quantitative sub-study nested within a cluster randomised trial in rural Malawi.
    Milanzi E; Mwapasa V; Joseph J; Jousset A; Tchereni T; Gunda A; Phiri J; Reece JC
    BMC Public Health; 2020 Dec; 20(1):1879. PubMed ID: 33287772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barriers to successful early infant diagnosis of HIV infection at primary care level in Malawi.
    Cromwell EA; Dow AE; Low D; Chirambo C; Heyderman RS; Dube Q; Van Rie A
    Pediatr Infect Dis J; 2015 Mar; 34(3):273-5. PubMed ID: 25742076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake of early infant diagnosis in Thailand's national program for preventing mother-to-child HIV transmission and linkage to care, 2008-2011.
    Naiwatanakul T; Voramongkol N; Punsuwan N; Lolekha R; Gass R; Thaisri H; Leechanachai P; Wolfe M; Boonsuk S; Bhakeecheep S
    J Int AIDS Soc; 2016; 19(1):20511. PubMed ID: 26968214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
    Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
    Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retention outcomes and drivers of loss among HIV-exposed and infected infants in Uganda: a retrospective cohort study.
    Kiyaga C; Narayan V; McConnell I; Elyanu P; Kisaakye LN; Kekitiinwa A; Price M; Grosz J
    BMC Infect Dis; 2018 Aug; 18(1):416. PubMed ID: 30134851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates and Predictors of HIV-Exposed Infants Lost to Follow-Up During Early Infant Diagnosis Services in Kenya.
    Goggin K; Hurley EA; Staggs VS; Wexler C; Nazir N; Gautney B; Khamadi SA; Maloba M; Lwembe R; Finocchario-Kessler S
    AIDS Patient Care STDS; 2019 Aug; 33(8):346-353. PubMed ID: 31369296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery.
    Giuliano M; Andreotti M; Liotta G; Jere H; Sagno JB; Maulidi M; Mancinelli S; Buonomo E; Scarcella P; Pirillo MF; Amici R; Ceffa S; Vella S; Palombi L; Marazzi MC
    PLoS One; 2013; 8(7):e68950. PubMed ID: 23894379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake of antiretroviral therapy in HIV-positive women ever enrolled into 'prevention of mother to child transmission' programme, Mandalay, Myanmar-a cohort study.
    Kyaw KWY; Satyanarayana S; Phyo KH; Kyaw NTT; Mon AA; Lwin TT; Aung TK; Oo MM; Aung ZZ; Htun T; Kham NSN; Mya T; Kumar AMV; Oo HN
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):474. PubMed ID: 30514239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with retention in Option B+ in Malawi: a case control study.
    Hoffman RM; Phiri K; Parent J; Grotts J; Elashoff D; Kawale P; Yeatman S; Currier JS; Schooley A
    J Int AIDS Soc; 2017 Apr; 20(1):21464. PubMed ID: 28453243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with retention of mother-baby pairs in the elimination of mother-to-child transmission of HIV program in Kaberamaido district: A longitudinal analysis.
    Odongo JD; Opito R; Wanume B; Bwayo D; Mukunya D; Okware S; Matovu JKB
    PLoS One; 2023; 18(7):e0288562. PubMed ID: 37478084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risks associated with mother-to-child transmission of HIV infection.
    Nguefack F; Ndombo PK; Ngoh R; Fru FS; Kinkela MN; Chiabi A
    Turk J Pediatr; 2017; 59(4):426-433. PubMed ID: 29624223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of maternal ART on mother-to-child transmission (MTCT) of HIV at six weeks postpartum in Rwanda.
    Mugwaneza P; Lyambabaje A; Umubyeyi A; Humuza J; Tsague L; Mwanyumba F; Mutabazi V; Nsanzimana S; Ribakare M; Irakoze A; Mutaganzwa E; Lombard C; Jackson D
    BMC Public Health; 2018 Nov; 18(1):1248. PubMed ID: 30419870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa.
    Larsen A; Magasana V; Dinh TH; Ngandu N; Lombard C; Cheyip M; Ayalew K; Chirinda W; Kindra G; Jackson D; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):789. PubMed ID: 31526366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.